QR code

Evolutionary measures show that recurrence of DCIS is distinct from progression to breast cancer

Abstract Background Progression from pre-cancers like ductal carcinoma in situ (DCIS) to invasive disease (cancer) is driven by somatic evolution and is altered by clinical interventions. We hypothesized that genetic and/or phenotypic intra-tumor heterogeneity would predict clinical outcomes for DCI...

Volledige beschrijving

Bewaard in:
Hoofdauteurs: Angelo Fortunato, Diego Mallo, Luis Cisneros, Lorraine M. King, Aziz Khan, Christina Curtis, Marc D. Ryser, Joseph Y. Lo, Allison Hall, Jeffrey R. Marks, E. Shelley Hwang, Carlo C. Maley
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BMC 2025-03-01
Reeks:Breast Cancer Research
Onderwerpen:
Ductal carcinoma in situ
Recurrence
Progression
Intratumor heterogeneity
Evolutionary biomarkers
Tumor evolution
Online toegang:https://doi.org/10.1186/s13058-025-01966-2
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items